Effect of Follicular Flushing in Patients With Mono-follicular Growth Undergoing In Vitro Fertilization

Sponsor
Centrum Clinic IVF Center (Other)
Overall Status
Completed
CT.gov ID
NCT03831542
Collaborator
(none)
71
1
2.5
28.4

Study Details

Study Description

Brief Summary

Retrieval of an oocyte from a follicle relies on the release of the cumulus-oocyte-complex (COC) from the follicular wall into the lumen, thereby allowing aspiration by a needle. Flushing the follicle with multiple aspirations from the same follicle is used as a means to increase the ratio of COC per aspirated follicle. Data showed that follicular flushing is not superior to direct aspiration either in normally responding patients or in poor responders undergoing in vitro fertilization (IVF). There is no data in the literature regarding the issue in patients with mono-follicular growth. Direct aspiration or repeatedly flushing the follicle for those with a single follicle will be investigated.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: direct follicular aspiration
  • Behavioral: follicular flushing

Detailed Description

Oocyte retrieval procedure This study aims to evaluate the effect of follicular flushing during oocyte retrieval procedure in patients with only one follicle. Double lumen needle will be used and direct follicular aspiration without flushing will be performed for all patients. If an oocyte will be obtained, the patient will be assigned to group A. If not, at least 1 course of follicular flushing will be used until retrieval of an oocyte and the patient will be assigned to group B.

Study Design

Study Type:
Observational
Actual Enrollment :
71 participants
Observational Model:
Case-Control
Time Perspective:
Prospective
Official Title:
Follicular Flushing in Patients With Mono-follicular Growth
Actual Study Start Date :
Feb 19, 2019
Actual Primary Completion Date :
May 5, 2019
Actual Study Completion Date :
May 6, 2019

Arms and Interventions

Arm Intervention/Treatment
direct aspiration group

Transvaginal ultrasound-guided oocyte retrieval was performed 36 hours after ovulation trigger. A 17-gauge double lumen needle will be used to aspirate a single follicle without flushing. If an oocyte is obtained, the subject will be assigned to group 1. If not, operator will proceed with follicular flushing.

Behavioral: direct follicular aspiration
direct follicular aspiration

flushing group

If an oocyte is not obtained with direct aspiration, operator will proceed to follicular flushing and the subject will be assigned to group 2 if an oocyte is obtained following follicular flushing.

Behavioral: follicular flushing
follicular flushing

Outcome Measures

Primary Outcome Measures

  1. mature oocyte [during oocyte retrieval procedure]

    Confirmation of cumulus oocyte complex (COC) after microscopic examination of follicular fluid by a senior embryologist for each patient.

Secondary Outcome Measures

  1. fertilization rate after micro-injection [24 hours after microinjection procedure]

    Confirmation of pronuclei formation on the following day of microinjection by a senior embryologist in each patient.

  2. clinical pregnancy rate per embryo transfer [untill 6 weeks]

    Confirmation of fetal cardiac activity on 5th or 6th week of gestation by a senior obstetrician in each pregnancy case.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 40 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • women aged 18-40 years

  • primary infertility

  • diminished ovarian reserve with single mature follicle on the day of oocyte retrieval

Exclusion Criteria:
  • natural cycle IVF

  • presence of endometriosis/endometrioma(s)

  • Absence of cumulus oocyte complex following oocyte retrieval

  • Severe male factor infertility

  • Pre-implantation genetic screening cycles

Contacts and Locations

Locations

Site City State Country Postal Code
1 Centrum Clinic IVF Center Ankara Turkey 06700

Sponsors and Collaborators

  • Centrum Clinic IVF Center

Investigators

  • Study Director: Emre Pabuccu, MD, Centrum Clinic IVF Center

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Emre Göksan Pabuçcu, Emre G. Pabuccu, Assoc. Prof., Centrum Clinic IVF Center
ClinicalTrials.gov Identifier:
NCT03831542
Other Study ID Numbers:
  • 1
First Posted:
Feb 6, 2019
Last Update Posted:
May 7, 2019
Last Verified:
May 1, 2019
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Emre Göksan Pabuçcu, Emre G. Pabuccu, Assoc. Prof., Centrum Clinic IVF Center
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 7, 2019